Tiziana Life Sciences up 91% on inhalable treatment for COVID-19 [Seeking Alpha]
Tiziana Life Sciences Ltd - Common Shares (TLSA)
Company Research
Source: Seeking Alpha
Healthcare|On the MoveTiziana Life Sciences up 91% on inhalable treatment for COVID-19Apr. 9, 2020 6:40 AM ETTiziana Life Sciences PLC (TLSA)Douglas W. HouseThinly traded nano cap Tiziana Life Sciences plc (NASDAQ:announcementThe company says the technology advances its IL-6 candidate TZLS-501 for the potential treatment of COVID-19, adding that it could be useful with other antibodies and drugs. A provisional patent application has been filed.It acquired the candidate from Swiss biotech Novimmune in 2017.IL-6 is a proinflammatory cytokine (protein) that is believed to play a key role in the development of severe lung damage in severely ill COVID-19 patients with acute respiratory distress syndrome.IL-6 inhibitor-related tickers: Regeneron Pharmaceuticals (NASDAQ:REGNSNYOTCQX:RHHBYSee all stocks on the move »Now read:Verastem Oncology: An Undervalued KRAS Oncology Play »
Show less
Read more
Impact Snapshot
Event Time:
TLSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLSA alerts
High impacting Tiziana Life Sciences Ltd - Common Shares news events
Weekly update
A roundup of the hottest topics
TLSA
News
- Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRAGlobeNewswire
- While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership [Yahoo! Finance]Yahoo! Finance
- Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal ForalumabGlobeNewswire
- Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary SharesGlobeNewswire
- Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 MillionGlobeNewswire
TLSA
Sec Filings
- 2/25/26 - Form 6-K
- 2/20/26 - Form S-8
- 1/22/26 - Form AW
- TLSA's page on the SEC website